Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 56Leukemia, Myeloid, Acute 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Hodgkin Disease 22Lymphoma, Non-Hodgkin 21Multiple Myeloma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Myeloproliferative Disorders 15Lymphoma 12Leukemia, Myelomonocytic, Chronic 11Leukemia, Biphenotypic, Acute 10Anemia, Refractory, with Excess of Blasts 10Blast Crisis 9Neoplasms, Plasma Cell 8Lymphoma, B-Cell, Marginal Zone 8Burkitt Lymphoma 8Primary Myelofibrosis 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Congenital Abnormalities 7Leukemia, Myelomonocytic, Juvenile 6Leukemia, Myeloid, Chronic-Phase 6Graft vs Host Disease 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Myeloid, Accelerated Phase 5Hematologic Neoplasms 5

Interventions

Imatinib Mesylate 5venetoclax 1ruxolitinib 1pevonedistat 1nilotinib 1Watchful Waiting 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Cytarabine 1Cladribine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypereosinophilic Syndrome × Granulocyte Colony-Stimulating Factor × Myeloid × Clear all
NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

M.D. Anderson Cancer Center

Phase 2 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡